Amgen Inc. (AMGN)
NASDAQ: AMGN · Real-Time Price · USD
281.21
-2.57 (-0.91%)
At close: May 2, 2025, 4:00 PM
281.00
-0.21 (-0.08%)
After-hours: May 2, 2025, 4:34 PM EDT
-0.91%
Market Cap 151.20B
Revenue (ttm) 34.13B
Net Income (ttm) 5.93B
Shares Out 537.65M
EPS (ttm) 10.94
PE Ratio 25.70
Forward PE 13.60
Dividend $9.52 (3.39%)
Ex-Dividend Date May 16, 2025
Volume 4,537,203
Open 288.14
Previous Close 283.78
Day's Range 275.41 - 288.14
52-Week Range 253.30 - 346.85
Beta 0.50
Analysts Buy
Price Target 323.65 (+15.09%)
Earnings Date May 1, 2025

About AMGN

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company’s principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet’s disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascul... [Read more]

Sector Healthcare
Founded 1980
Country United States
Stock Exchange NASDAQ
Ticker Symbol AMGN
Full Company Profile

Financial Performance

In 2024, Amgen's revenue was $33.42 billion, an increase of 18.57% compared to the previous year's $28.19 billion. Earnings were $4.09 billion, a decrease of -39.11%.

Financial Statements

Analyst Forecast

According to 21 analysts, the average rating for AMGN stock is "Buy." The 12-month stock price forecast is $323.65, which is an increase of 15.09% from the latest price.

Price Target
$323.65
(15.09% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Amgen: Reducing My Price Target, Reiterate Buy After A Solid Q1

Amgen reported strong Q1 results with a 9% YoY revenue increase and a 24% rise in operating EPS, but shares dipped due to risk-on market sentiment. Despite competitive pressures and softer EPS trends,...

3 hours ago - Seeking Alpha

Dogs Of The Dow Chase May's 'Safer' Buy

Verizon is the only Dow Dog meeting the ideal of annual dividends from $1K invested exceeding the single share price, supported by adequate free cash flow. Analyst projections suggest top Dow Dogs cou...

Other symbols: AMZNBACRMCSCOCVXDISGS
1 day ago - Seeking Alpha

Committee Movers: Eaton Corp PLC, Blackstone, Amgen, EOG Resources, Chevron and Exxon Mobile

Watch as the Investment Committee breaks down the latest market movers and shakers.

Other symbols: BXCVXEOGETNXOM
1 day ago - CNBC Television

Amgen Inc. (AMGN) Q1 2025 Earnings Call Transcript

Amgen Inc. (NASDAQ:AMGN) Q1 2025 Earnings Conference Call May 1, 2025 4:30 PM ET Company Participants Justin Claeys - VP, IR Robert Bradway - Chairman, CEO & President Murdo Gordon - EVP, Global Comm...

2 days ago - Seeking Alpha

Amgen quarterly profit tops Wall Street view, sales up 11%

Amgen on Thursday said its first-quarter profit rose 24%, handily exceeding Wall Street expectations, as product sales increased 11% and profit margins widened.

2 days ago - Reuters

AMGEN REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS

THOUSAND OAKS, Calif. , May 1, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced financial results for the first quarter of 2025.

2 days ago - PRNewsWire

AMGEN ANNOUNCES WEBCAST OF 2025 FIRST QUARTER FINANCIAL RESULTS

THOUSAND OAKS, Calif. , April 28, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it will report its first quarter 2025 financial results on Thursday, May 1, 2025, after the close of the...

5 days ago - PRNewsWire

Amgen CEO announces $1 billion in new investments

Amgen chairman and CEO Robert Bradway unpacks the company's investments on 'The Claman Countdown.'

8 days ago - Fox Business

Amgen to expand Ohio biotech manufacturing plant

Amgen on Friday announced a $900 million expansion of its Ohio biotech manufacturing facility, becoming the latest in a string of drugmakers pledging to increase U.S. capacity amid Trump administratio...

9 days ago - Reuters

AMGEN ANNOUNCES $900 MILLION MANUFACTURING EXPANSION, CREATION OF 350 NEW JOBS IN OHIO

Total Investment in the State to Exceed $1.4 Billion, 750 U.S. Jobs THOUSAND OAKS, Calif. , April 25, 2025 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced a $900 million expansion of its Ohio man...

9 days ago - PRNewsWire

Exclusive: US pharma tariffs would raise US drug costs by $51 bln annually, report finds

A 25% U.S. tariff on pharmaceutical imports would increase U.S. drug costs by nearly $51 billion annually, boosting U.S. prices by as much as 12.9% if passed on, a report commissioned by the industry'...

Other symbols: BMYLLYPFE
9 days ago - Reuters

Final Trades: Take-Two Interactive, Franco-Nevada, Amgen and the 10-Year Treasury

The Investment Committee give you their top stocks to watch for the second half.

Other symbols: FNVTTWO
13 days ago - CNBC Television

LLY, NVO and AMGN Forecast – Pharma Stocks to Open Mixed

The three pharma stocks in this analysis all look a bit mixed in the premarket, after seeing some momentum late last week. This is especially true with LLY, as you will see on the charts.

Other symbols: ABBVAZNBMYGSKJNJLLYMRK
13 days ago - FXEmpire

Amgen: The Biotech That Knows How To Make Money

Amgen's strategic growth through M&A and R&D investments has led to a diversified portfolio, with significant contributions from rare disease treatments and biosimilars. Financially robust, Amgen achi...

17 days ago - Seeking Alpha

Trump Says Pharmaceutical Tariffs Coming in Near Future

President Donald Trump said tariffs on pharmaceuticals will be coming in the “not too distant future” and fit in the category of tariffs imposed on cars, steel, and aluminum. Trump spoke with reporter...

Other symbols: ABBVAZNBMYGSKIBBJNJLLY
19 days ago - Bloomberg Markets and Finance

Trump says US pharma tariffs coming in not-too-distant future

U.S. President Donald Trump said on Monday that he expects to impose tariffs on imported pharmaceuticals in the not-too-distant future.

Other symbols: ABBVAZNBMYGSKJNJLLYMRK
20 days ago - Reuters

Switzerland's Sandoz files antitrust lawsuit against Amgen in US

Swiss generic drug manufacturer Sandoz said on Monday it had filed an antitrust lawsuit in the U.S. against Amgen for entrenching the dominant market position of its blockbuster medicine, Enbrel (etan...

20 days ago - Reuters

Trump's pharmaceutical tariffs could raise costs for patients, worsen drug shortages

President Donald Trump's planned tariffs on pharmaceuticals imported into the U.S. could have wide-ranging consequences on the drug supply chain, manufacturers and American patients, some experts told...

Other symbols: ABBVAZNBMYGSKIBBJNJLLY
23 days ago - CNBC

IMDELLTRA® DEMONSTRATED SUPERIOR OVERALL SURVIVAL IN SMALL CELL LUNG CANCER

First Global Phase 3 Trial Showing Substantial Survival Advantage Over Chemotherapy, for Patients With Progression On or After Platinum-Based Chemotherapy THOUSAND OAKS, Calif. , April 11, 2025 /PRNew...

23 days ago - PRNewsWire

Autos, pharma, luxury and more: The global sectors soaring after Trump's tariffs walkback

European stocks soared on Thursday after U.S. President Donald Trump's jarring about-turn on most tariffs. Tensions between Washington and Beijing remain high, however, with Trump ratcheting up duties...

Other symbols: ABBVAZNBMYGSKJNJLLYMRK
24 days ago - CNBC

BMO's Siegerman talks the impact of tariffs on pharmaceutical stocks

Evan Seigerman, BMO, joins 'Fast Money' to talk the impact of tariffs on pharma space.

Other symbols: ABBVAZNBMYGSKJNJLLYMRK
24 days ago - CNBC Television

Trump's Tariffs Circle Pharma Industry: Who It Affects And How It May Play Out

The Trump administration's proposed tariffs on pharmaceuticals have caused significant market turmoil today, with major Pharma stocks plummeting globally. Despite pledges to increase U.S. manufacturin...

Other symbols: ABBVAZNBMYGSKJNJLLYMRK
24 days ago - Seeking Alpha

Explainer: Prescription drugs become a target in Trump's trade war

U.S. President Donald Trump late on Tuesday reiterated he would impose tariffs on imports of pharmaceutical products that have long been spared from past trade disputes due to the potential for harm t...

Other symbols: ABBVAZNBMYGSKIBBJNJLLY
24 days ago - Reuters

Healthy Returns: Trump says major pharmaceutical tariffs coming ‘very shortly'

Trump doubled down on plans to soon impose "major" pharmaceutical tariffs, while early stage startups dominated digital health funding deals in first quarter.

Other symbols: ABBVAZNBMYGSKIBBJNJLLY
25 days ago - CNBC

Pharma Stocks Slide Further After Trump Reiterates Tariff Threats on Drugs

Drugmakers have said they're still unclear about whether Trump will impose tariffs on finished products or on active pharmaceutical ingredients.

Other symbols: ABBVAZNBMYGSKJNJLLYMRK
25 days ago - WSJ